Targeted immune epitope prediction to HHLA2 and MAGEB5 protein variants as therapeutic approach to related viral diseases

BACKGROUND: Targeted immunotherapy is mostly associated with cancer treatment wherein designed molecules engage signaling pathways and mutant proteins critical to the survival of the cell. One of several genetic approaches is the use of in silico methods to develop immune epitopes targeting specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Achinko, Daniel A., Dormer, Anton, Narayanan, Mahesh, Norman, Elton F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316541/
https://www.ncbi.nlm.nih.gov/pubmed/34320928
http://dx.doi.org/10.1186/s12865-021-00440-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316541/
https://www.ncbi.nlm.nih.gov/pubmed/34320928
http://dx.doi.org/10.1186/s12865-021-00440-w

Ejemplares similares